| Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease DR Ashby, DP Gale, M Busbridge, KG Murphy, ND Duncan, TD Cairns, ... Kidney international 75 (9), 976-981, 2009 | 437 | 2009 |
| A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases N Arulkumaran, RJ Unwin, FWK Tam Expert opinion on investigational drugs 20 (7), 897-915, 2011 | 312 | 2011 |
| Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin DR Ashby, DP Gale, M Busbridge, KG Murphy, ND Duncan, TD Cairns, ... haematologica 95 (3), 505, 2010 | 268 | 2010 |
| Glomerular protein sieving and implications for renal failure in Fanconi syndrome AGW Norden, M Lapsley, PJ Lee, CD Pusey, SJ Scheinman, FWK Tam, ... Kidney international 60 (5), 1885-1892, 2001 | 262 | 2001 |
| CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis J Reynolds, FWK Tam, A Chandraker, J Smith, AM Karkar, J Cross, ... The Journal of clinical investigation 105 (5), 643-651, 2000 | 198 | 2000 |
| Antibody blockade of TNF-α reduces inflammation and scarring in experimental crescentic glomerulonephritis SB Khan, HT Cook, G Bhangal, J Smith, FWK Tam, CD Pusey Kidney international 67 (5), 1812-1820, 2005 | 196 | 2005 |
| Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin–angiotensin–aldosterone system inhibition MJ Kim, AH Frankel, M Donaldson, SJ Darch, CD Pusey, PD Hill, M Mayr, ... Kidney international 80 (8), 851-860, 2011 | 194 | 2011 |
| Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment DR Ashby, HE Ford, KJ Wynne, AM Wren, KG Murphy, M Busbridge, ... Kidney international 76 (2), 199-206, 2009 | 166 | 2009 |
| Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy FWK Tam, BL Riser, K Meeran, JA Rambow, CD Pusey, AH Frankel Cytokine 47 (1), 37-42, 2009 | 166 | 2009 |
| Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study WK Fenske, S Dubb, M Bueter, F Seyfried, K Patel, FWK Tam, AH Frankel, ... Surgery for Obesity and related diseases 9 (4), 559-568, 2013 | 153 | 2013 |
| Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis FWK Tam, JS Sanders, A George, T Hammad, C Miller, T Dougan, ... Nephrology Dialysis Transplantation 19 (11), 2761-2768, 2004 | 152 | 2004 |
| Urinary proteomic profiles distinguish between active and inactive lupus nephritis K Mosley, FWK Tam, RJ Edwards, J Crozier, CD Pusey, L Lightstone Rheumatology 45 (12), 1497-1504, 2006 | 140 | 2006 |
| Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes S Kazempour-Ardebili, VL Lecamwasam, T Dassanyake, AH Frankel, ... Diabetes care 32 (7), 1137-1142, 2009 | 139 | 2009 |
| P2X7 deficiency attenuates renal injury in experimental glomerulonephritis SRJ Taylor, CM Turner, JI Elliott, J McDaid, R Hewitt, J Smith, ... Journal of the American Society of Nephrology 20 (6), 1275-1281, 2009 | 139 | 2009 |
| Nonparenchymal cells from regenerating rat liver generate interleukin-1α and-1β: a mechanism of negative regulation of hepatocyte proliferation R Boulton, A Woodman, D Calnan, C Selden, F Tam, H Hodgson Hepatology 26 (1), 49-58, 1997 | 130 | 1997 |
| Urinary monocyte chemoattractant protein-1 in renal disease MJ Kim, FWK Tam Clinica chimica acta 412 (23-24), 2022-2030, 2011 | 129 | 2011 |
| Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors A Tanna, L Guarino, FWK Tam, B Rodriquez-Cubillo, JB Levy, TD Cairns, ... Nephrology Dialysis Transplantation 30 (7), 1185-1192, 2015 | 124 | 2015 |
| Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis CM Turner, FWK Tam, PC Lai, RM Tarzi, G Burnstock, CD Pusey, ... Nephrology Dialysis Transplantation 22 (2), 386-395, 2007 | 108 | 2007 |
| A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis J Smith, JP McDaid, G Bhangal, R Chawanasuntorapoj, ES Masuda, ... Journal of the American Society of Nephrology 21 (2), 231-236, 2010 | 103 | 2010 |
| Is the inflammasome a potential therapeutic target in renal disease? CM Turner, N Arulkumaran, M Singer, RJ Unwin, FWK Tam BMC nephrology 15, 1-13, 2014 | 102 | 2014 |
Stephen McAdooImperial College LondonVerified email at imperial.ac.uk
